Compounds > azomycin
Page last updated: 2024-08-21

azomycin and Carcinoma, Lewis Lung

azomycin has been researched along with Carcinoma, Lewis Lung in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujibayashi, Y; Fujieda, S; Furukawa, T; Kobayashi, M; Kudo, T; Mori, T; Oh, M; Tanaka, T1
Cerecetto, H; Dematteis, S; Fernández, S; Giglio, J; Moreno, M; Pacheco, JP; Pietzsch, HJ; Rey, A1
Cerecetto, H; Dematteis, S; Fernández, S; Giglio, J; Rey, A1
Ashino, H; Hazato, T; Hori, H; Inayama, S; Nagasawa, H; Shimamura, M; Uto, Y; Yamamoto, Y1

Other Studies

4 other study(ies) available for azomycin and Carcinoma, Lewis Lung

ArticleYear
Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:4

    Topics: Animals; Autoradiography; Bromodeoxyuridine; Carcinoma, Lewis Lung; Cell Proliferation; Colony-Forming Units Assay; Coordination Complexes; Copper Radioisotopes; Disease Models, Animal; Fluorodeoxyglucose F18; Hypoxia; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Staining and Labeling; Thiosemicarbazones

2009
Synthesis, in vitro and in vivo characterization of novel 99mTc-'4+1'-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:5

    Topics: Animals; Biological Transport; Blood Proteins; Carcinoma, Lewis Lung; Cell Hypoxia; Cell Line, Tumor; Chemistry Techniques, Synthetic; Female; Humans; Hydrophobic and Hydrophilic Interactions; Isotope Labeling; Ligands; Mice; Nitroimidazoles; Organotechnetium Compounds; Rhenium

2012
Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:2

    Topics: Animals; Biological Transport; Carcinoma, Lewis Lung; Cell Hypoxia; Cell Line, Tumor; Cell Transformation, Neoplastic; Chemistry Techniques, Synthetic; Gallium Radioisotopes; Humans; Hydrophobic and Hydrophilic Interactions; Isotope Labeling; Ligands; Mice; Nitroimidazoles; Positron-Emission Tomography

2013
A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
    British journal of cancer, 2003, Jan-27, Volume: 88, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Cattle; Cell Division; Chick Embryo; Chorion; Endothelial Growth Factors; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Hydroxamic Acids; Hypoxia; Imidazoles; Injections, Intraperitoneal; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Mice; Neovascularization, Pathologic; Nitro Compounds; Nitroimidazoles; Pulmonary Artery; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003